Skip to main content
Midas Edge

Aditxt, Inc.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

ADTX$0.00-8.6%Stored close · as of Jul 8, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Changes in Stockholders’ Equity

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

YEAR ENDED DECEMBER 31, 2025 AND 2024

Preferred A-1 Shares · Preferred A-1 Shares Par · Preferred B-1 Shares · Preferred B-1 Shares Par · Preferred B-2 Shares · Preferred B-2 Shares Par · Common Shares Outstanding · Common Shares Par · Treasury Stock · Additional Paid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · Non- Controlling Interest · Total Stockholders’ Equity · Preferred C-1 Shares · Redeemable Preferred C-1 · Total Mezzanine Equity
Balance December 31, 202422,071$222,689$32,625$3193$1$(201,605)$169,970,721$(168,094,569)$-$(583,180)$1,091,3967,195$7,195,000$7,195,000
Issuance of shares for registered direct offering, net of issuance costs------348,778352-17,846,356---17,846,708---
Issuance of shares under ELOC, net of issuance costs------55,21856-28,531,461---28,531,517---
Redemption of C-1 preferred stock---------(917,069)---(917,069)(4,932)(6,110,000)(6,110,000)
Reclass of C-1 preferred stock to Mandatorily Redeemable Preferred Stock---------(163,440)---(163,440)(2,263)(1,085,000)(1,085,000)
Acquisition of patent---------10,000---10,000---
Redemption of A-1 preferred stock(529)--------(308,000)---(308,000)---
Reclass of A-1 preferred stock to Mandatorily Redeemable Preferred Stock(678)(1)-------(1,079,046)---(1,079,047)---
Warrants issued for services---------473,311---473,311---
Rounding from reverse stock split------7,3103-1,176---1,179---
Change in valuation of Evofem note-----------1,254,170-1,254,170---
Net loss----------(41,714,201)-(1,072,842)(42,787,043)---
Balance December 31, 202520,864$212,689$32,625$3411,499$412$(201,605)$214,365,470$(209,808,770)$1,254,170$(1,656,022)$3,953,682-$-$-

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

YEAR ENDED DECEMBER 31, 2025 AND 2024

Preferred A-1 Shares · Preferred A-1 Shares Par · Preferred B-1 Shares · Preferred B-1 Shares Par · Preferred B-2 Shares · Preferred B-2 Shares Par · Preferred D-1 Shares · Preferred D-1 Shares Par · Common Shares Outstanding · Common Shares Par · Treasury Stock · Additional Paid-in Capital · Accumulated Deficit · Non- Controlling Interest · Total Stockholders’ Equity · Preferred C-1 Shares · Redeemable Preferred C-1 · Total Mezzanine Equity
Balance December 31, 202322,280$22-$-2,625$3-$-41$-$(201,605)$143,999,018$(127,741,072)$(9,608)$16,046,758-$-$-
Stock option compensation-----------32,918--32,918---
MDNA asset purchase--------1--1,008,668--1,008,668---
Brain asset purchase--6,0006-------5,970,437--5,970,443---
Issuance of shares for settlement--------1--1,599,999--1,599,999---
Restricted stock unit compensation--------1--153--153---
Issuance of shares for offering, net of issuance costs------4,1864---(532,164)--(532,160)4,1864,186,0004,186,000
Issuance of shares for debt issuance costs--------1--662,717--662,717---
Modification of warrants-----------4,137(4,137)-----
Issuance of shares for registered direct offering, net of issuance costs--------36--3,022,939--3,022,939---
Issuance of shares under ELOC, net of issuance costs--------1051-12,739,556--12,739,557---
Exchange of warrants for Series C-1 Convertible Preferred Stock-----------(6,000,006)--(6,000,006)6,0006,000,0006,000,000
Liquidation damages-----------(1)--(1)667667,000667,000
Conversion of Series A-1 Convertible Preferred stock(209)-------1--(1)--(1)---
Conversion of Series B-1 Convertible Preferred stock--(3,311)(3)----4--1--(2)---
Exercise of warrants--------1--1,246,489--1,246,489---
Issuance of warrants as debt issuance costs-----------913,713--913,713---
Modifications of warrants as debt issuance costs-----------376,901--376,901---
Modifications of warrants-----------5,902,874(5,902,874)-----
Derivative liability from conversion feature on preferred stock-----------(429,018)--(429,018)---
Rounding from reverse stock split--------1--21--21---
Redemption of C-1 preferred stock-----------(548,602)--(548,602)(3,658)(3,658,000)(3,658,000)
Redemption of D-1 preferred stock------(4,186)(4)---(28)--(32)---
Net loss------------(34,446,486)(573,572)(35,020,058)---
Balance December 31, 202422,071$222,689$32,625$3-$-193$1$(201,605)$169,970,721$(168,094,569)$(583,180)$1,091,3967,195$7,195,000$7,195,000
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.